Annual Total Expenses
$18.87 M
+$3.60 M+23.57%
December 31, 2023
Summary
- As of February 7, 2025, CNSP annual total expenses is $18.87 million, with the most recent change of +$3.60 million (+23.57%) on December 31, 2023.
- During the last 3 years, CNSP annual total expenses has risen by +$9.41 million (+99.53%).
- CNSP annual total expenses is now at all-time high.
Performance
CNSP Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Expenses
$5.63 M
+$3.10 M+122.65%
September 30, 2024
Summary
- As of February 7, 2025, CNSP quarterly total expenses is $5.63 million, with the most recent change of +$3.10 million (+122.65%) on September 30, 2024.
- Over the past year, CNSP quarterly total expenses has increased by +$1.10 million (+24.15%).
- CNSP quarterly total expenses is now at all-time high.
Performance
CNSP Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
CNSP Total Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +23.6% | +24.1% |
| 3 y3 years | +99.5% | +47.6% |
| 5 y5 years | +2039.4% | +47.6% |
CNSP Total Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +30.2% | at high | +122.7% |
| 5 y | 5-year | at high | +392.2% | at high | +186.0% |
| alltime | all time | at high | +2039.4% | at high | +3213.1% |
CNS Pharmaceuticals Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $5.63 M(+122.7%) |
| Jun 2024 | - | $2.53 M(-28.7%) |
| Mar 2024 | - | $3.54 M(-34.1%) |
| Dec 2023 | $18.87 M(+23.6%) | $5.38 M(+18.7%) |
| Sep 2023 | - | $4.53 M(+12.6%) |
| Jun 2023 | - | $4.03 M(-18.3%) |
| Mar 2023 | - | $4.93 M(-4.1%) |
| Dec 2022 | $15.27 M(+5.4%) | $5.13 M(+50.2%) |
| Sep 2022 | - | $3.42 M(-4.1%) |
| Jun 2022 | - | $3.56 M(+13.2%) |
| Mar 2022 | - | $3.15 M(-3.1%) |
| Dec 2021 | $14.49 M | $3.25 M(-14.7%) |
| Sep 2021 | - | $3.81 M(+0.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2021 | - | $3.81 M(+5.6%) |
| Mar 2021 | - | $3.61 M(+20.3%) |
| Dec 2020 | $9.45 M(+146.7%) | $3.00 M(+49.3%) |
| Sep 2020 | - | $2.01 M(-18.7%) |
| Jun 2020 | - | $2.47 M(+25.7%) |
| Mar 2020 | - | $1.97 M(-22.0%) |
| Dec 2019 | $3.83 M(+334.7%) | $2.52 M(+261.0%) |
| Sep 2019 | - | $699.10 K(+68.4%) |
| Jun 2019 | - | $415.10 K(+112.8%) |
| Mar 2019 | - | $195.10 K(-6.5%) |
| Dec 2018 | $881.80 K | $208.60 K(+22.8%) |
| Sep 2018 | - | $169.90 K(-13.6%) |
| Jun 2018 | - | $196.60 K |
FAQ
- What is CNS Pharmaceuticals annual total expenses?
- What is the all time high annual total expenses for CNS Pharmaceuticals?
- What is CNS Pharmaceuticals annual total expenses year-on-year change?
- What is CNS Pharmaceuticals quarterly total expenses?
- What is the all time high quarterly total expenses for CNS Pharmaceuticals?
- What is CNS Pharmaceuticals quarterly total expenses year-on-year change?
What is CNS Pharmaceuticals annual total expenses?
The current annual total expenses of CNSP is $18.87 M
What is the all time high annual total expenses for CNS Pharmaceuticals?
CNS Pharmaceuticals all-time high annual total expenses is $18.87 M
What is CNS Pharmaceuticals annual total expenses year-on-year change?
Over the past year, CNSP annual total expenses has changed by +$3.60 M (+23.57%)
What is CNS Pharmaceuticals quarterly total expenses?
The current quarterly total expenses of CNSP is $5.63 M
What is the all time high quarterly total expenses for CNS Pharmaceuticals?
CNS Pharmaceuticals all-time high quarterly total expenses is $5.63 M
What is CNS Pharmaceuticals quarterly total expenses year-on-year change?
Over the past year, CNSP quarterly total expenses has changed by +$1.10 M (+24.15%)